Gunnar Hillerdal - Concepedia

Author

Gunnar Hillerdal

Also Known As

G HILLERDAL, G Hillerdal, G. HILLERDAL, G. Hillerdal, G. N. Hillerdal, G.N. Hillerdal, GUNNAR HILLERDAL, Gunnar HILLERDAL, Gunnar Hillerdal, Gunnar N Hillerdal

256

Publications

Citations

H-Index

117

Concepts

All Affiliations

Uppsala University Hospital Karolinska University Hospital Karolinska Institutet Eskişehir Osmangazi University

About

Gunnar Hillerdal is an author at Uppsala University Hospital specializing in medicine, pathology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	61	3.1K
2	Public Health	11	11	892
3	Health Sciences	5	5	269
4	Allergy	5	5	233
5	Allergy Medicine	1	1	10

Gunnar Hillerdal

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma Arnaud Scherpereel, Philippe Astoul, Paul Baas, European Respiratory Journal	2009	631
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM) Samuel V. Kemp, Dirk‐Jan Slebos, Alan Kirk, American Journal of Respiratory and Critical Care Medicine	2017	383
Sarcoidosis: epidemiology and prognosis. A 15-year European study. Gunnar Hillerdal, Nõu E, Kalevi Österman, PubMed Stage Ii SarcoidosisPulmonary InfiltrationClinical FindingOncologyPulmonary Pathology	1984	365
Malignant mesothelioma 1982: Review of 4710 published cases Gunnar Hillerdal British Journal of Diseases of the Chest Tumoral PathologyMedicineHistopathologyPathologyMalignant Mesothelioma 1982	1983	281
Increased Risk for Cancer Following Sarcoidosis Johan Askling, Johan Grünewald, Anders Eklúnd, American Journal of Respiratory and Critical Care Medicine	1999	261
Effect of delays on prognosis in patients with non-small cell lung cancer. Gunnar Mýrdal, Mats Lambe, Gunnar Hillerdal, PubMed	2004	243
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial Lee M. Krug, Hedy L. Kindler, Hilary Calvert, The Lancet Oncology Surgical OncologyMedicinePrevious ChemotherapyPleural DiseasePlacebo-controlled Trial	2015	219
Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group Christer Sederholm, Gunnar Hillerdal, Kristina Lamberg, Journal of Clinical Oncology	2005	215
Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases Muzaffer Metintaş, İrfan Uçgun, Osman Elbek, European Journal of Radiology Malignant Pleural MesotheliomaHealth SciencesMedical ImagingPathologyTomography Features	2002	172
Patient's and doctors’ delays in the diagnosis of chest tumors Hirsh Koyi, Gunnar Hillerdal, Eva Brandén Lung Cancer Chest TumorsMedicineDiagnosisPulmonary BlastomaOncology	2002	134

Page 1